logo-top-r-w
  • HOME
  • ABOUT MORSE
    • The Team
    • Strategic Partners
      • Lorraine Boyle
      • Dominika Dabrowski
      • Stephen Filbey
      • Brent Korte
    • Careers
  • SERVICES
    • Our Services
    • Strategic Advice
      • MORSE HTA Strategic Advice
    • Analyses
    • Advisory Boards
      • MORSE Advisory Panel (MAP)
    • Training
      • Private Payer
      • Negotiation Simulation
      • Reimbursement Training
    • Reports
      • Canadian Reimbursement and Forecasting Timelines Report (CRaFT)
      • Oncology and Biosimilar Sub-Report
  • NEWS
    • MORSE Signals
    • MORSE Wire
    • Publications
    • What’s New
  • EVENTS
  • LINKS
  • CONTACT US
logo-top-c-r
logo-top-r-w
  • HOME
  • ABOUT MORSE
    • The Team
    • Strategic Partners
      • Lorraine Boyle
      • Dominika Dabrowski
      • Stephen Filbey
      • Brent Korte
    • Careers
  • SERVICES
    • Our Services
    • Strategic Advice
      • MORSE HTA Strategic Advice
    • Analyses
    • Advisory Boards
      • MORSE Advisory Panel (MAP)
    • Training
      • Private Payer
      • Negotiation Simulation
      • Reimbursement Training
    • Reports
      • Canadian Reimbursement and Forecasting Timelines Report (CRaFT)
      • Oncology and Biosimilar Sub-Report
  • NEWS
    • MORSE Signals
    • MORSE Wire
    • Publications
    • What’s New
  • EVENTS
  • LINKS
  • CONTACT US

MORSE Consulting Welcomes WestPAR as a New Strategic Partner

September 11, 2017
-
What's New
-
Posted by MORSE Team - 2 min read.

Toronto, September 11, 2017 – Arvind Mani and Sherry O’Quinn are pleased to announce our newest strategic partner: Stephen Filbey of WestPAR – Western Policy Access & Reimbursement Consultancy.

Stephen is the founder and Principal Executive Consultant of his Vancouver based company, WestPAR Consultancy Inc. He is an accomplished professional with 30+ years of experience in the pharmaceutical and related industries, 27 of which have been focused on issues throughout the western provinces. Over the ten most recent years, he has worked with more than 40 organization in solving a variety of market access, reimbursement, policy and advocacy challenges throughout Western Canada. His work spans a broad spectrum of therapeutic areas in the rare disease, oncology and non-oncology markets. A decade of involvement and advising extensively on Biosimilars, has refined his instincts in this unique subset of pharmaceuticals; and complimentary to his Western Canada focus, is a decade of Budget Impact Analysis (BIA) modelling expertise. He has successfully negotiated multiple agreements with BC PharmaCare, BC Cancer Agency, Alberta Health, Saskatchewan Pharmaceutical Services Unit and the Saskatchewan Cancer Agency. Stephen holds a Bachelor’s degree in Science from the University of Windsor and has completed a Continuing Medical Education & Needs Assessment Internship through the department of CME at the University of Calgary.

“As one of MORSE’s strategic partners, I offer a broad base of complimentary strategic skills, connections, and experience throughout the western provinces while sharing the values of trust, honesty, and integrity. The collaboration between WestPAR and MORSE, mutually expands our presence and expertise and I am thrilled to be able to apply my leadership in the budget impact analysis modelling sector of their business. I look forward to the accomplishments our collective team approach will secure for our clients.”

Stephen provides expertise related to market access strategies for Western provinces and leads the development of budget impact analysis models for MORSE’s clients.

With the announcement of this partnership with WestPAR, coupled with our existing linkages with Brent Korte (IMPACT) and Dominika Dabrowski (DKDA Consulting), MORSE is poised to offer a wider array of strategic reimbursement services to our clients.

Share
Tags
Advocacy
BIA
Budget Impact Analysis
Market Access Strategy
MORSE Team
Western Canada
WestPAR
← PREVIOUS POST
pCPA Update as of August 31, 2017
NEXT POST →
Upcoming Market Access Events / Conferences – September 2017

Contact Us
MORSE Consulting Inc.
Toronto | Ottawa, Canada
+1-647-717-3179 (Toronto)
+1-613-864-8645 (Ottawa)
info@morseconsulting.ca
Social
Connect & Follow:

New Report

Newsletter – MORSE Signals
Sign up for our free e-mail newsletter service and receive timely and relevant updates related to the emerging developments in the Canadian pharmaceutical reimbursement landscape.

Sign Up
MORSE Consulting Inc. | Deciphering Canadian pharmaceutical market access signals to create reimbursement success.
© 2021 MORSE Consulting Inc. All rights reserved. | Site by Directica Media
MORSE Consulting Welcomes WestPAR as a New Strategic Partner
Private
Public
Private

INESSS
CADTH

HTA

pCPA

Public Payers

Health Canada

Patients

Private Payers

PMPRB

Public
INESSS
CADTH

HTA

pCPA

Public Payers

Health Canada

Patients

Private Payers

PMPRB
Public
Private
Public
INESSS
CADTH

HTA

pCPA

Public Payers

Health Canada

Patients

Private Payers

PMPRB
Private

INESSS
CADTH

HTA

pCPA

Public Payers

Health Canada

Patients

Private Payers

PMPRB